Pliant Therapeutics promotes Minnie Kuo to COO effective December 10, 2025

PLIANT THERAPEUTICS, INC.

Minnie Kuo appointed Chief Operating Officer, effective immediately; previously served as Chief Development Officer since September 2023.
Ms. Kuo has over 20 years of multinational clinical development experience, including senior roles at Vir Biotechnology, Gilead Sciences, and Roche/Genentech.
No additional compensation provided with the COO appointment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.